Asabys Partners, member of CataloniaBio & HealthTech, along with companies such as Novator Partners, Frumtak Ventures, and Wellington Partners, are prominent investors in Sidekick Health. Asabys participated in the $55 million funding round in May 2022, which laid the foundation for the company to continue growing and innovating, generating a greater impact in the digital health and therapeutic sectors.
Today, Sidekick Health aims to transform the landscape of digital therapies with the strategic acquisition of aidhere, a Prescription Digital Therapeutics (PDT) developer based in Germany. This operation highlights Sidekick Health's commitment to driving the impact of digital health and its expansion in the market for prescription digital therapies, working in collaboration with healthcare providers.
Sidekick Health CEO, Dr. Tryggvi Thorgeirsson, shared that the decision to acquire aidhere arose from the shared vision of the two organizations on PDTs and their cultural alignment. "Developing and distributing prescription digital therapies has always been a key topic in our long-term vision, and when we got to know aidhere's solutions and exceptional team in detail, we knew we had to join forces," commented Thorgeirsson.
This acquisition places Sidekick Health at the forefront of the industry and provides a new offering of digital solutions for insurers in the United States, as well as co-development of prescription digital therapeutic products with pharmaceutical companies globally. With the integration of aidhere's experience and products, Sidekick Health strengthens its position as a trusted partner of large health insurers and pharmaceutical multinationals.
Comments